Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.50 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.50 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.50 |
| ▸ | PI4KA | P42356 | 1/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.50 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11541937 | 0.89 | CYP2D6 (0.60) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL29683245 | 0.79 | CYP19A1 (0.52) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL17246864 | 0.79 | CYP19A1 (0.52) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL1724136 | 0.79 | PIK3CD (0.47) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL30639581 | 0.79 | CYP2C19 (0.49) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL27032937 | 0.79 | CYP2C19 (0.49) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL9159421 | 0.79 | ALDH1A1 (0.53) | METAP2ALDH1A1TP53MAPTNPC1 | |
| SCHEMBL3156768 | 0.78 | CYP2D6 (0.51) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL999538 | 0.78 | CYP19A1 (0.51) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD | |
| SCHEMBL31140236 | 0.78 | CYP2D6 (0.56) | CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115943190-A | Multifunctional material for temporary bonding | 布鲁尔科技公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115461471-A | Chip surface connector and preparation method and application thereof | 南京金斯瑞生物科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-112608474-A | Polyimide film and graphite film | 浙江中科玖源新材料有限公司 | 2021-04-06 | — | — | CN | claimed |
| CN-110003470-A | A kind of polyimide material and preparation method thereof applied to flexible display substrates | 中国科学院长春应用化学研究所 | 2019-07-12 | — | — | CN | claimed |
| CN-108368494-A | Methods, compositions and uses of novel FYN kinase inhibitors | 沃伦·C·刘 | 2018-08-03 | — | — | CN | claimed |
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| EP-4695236-A1 | SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE | Soley Therapeutics, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-3717459-B1 | COMPOUNDS | STEP PHARMA S A S (FR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4559908-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | S2CBio Inc. (KR) | 2025-05-28 | — | — | EP | disclosed |
| CN-113727972-B | Novel hydrazone derivatives having terminal amine groups substituted with aryl or heteroaryl groups and use thereof | 韩国科学技术研究院 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024216094-A1 | SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE | SOLEY THERAPEUTICS, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2024058617-A1 | ANTIVIRAL USE OF HETEROARYL DERIVATIVE COMPOUND | 일동제약(주) | 2024-03-21 | — | — | WO | disclosed |
| WO-2015094119-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-25 | — | — | WO | disclosed |
| WO-2014078294-A1 | INDOLE COMPOUNDS AND THEIR USE AS ANTIMICROBIALS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2014-05-22 | — | — | WO | disclosed |
| WO-2014060112-A1 | PYRAZOLO[4,3-D]PYRIMIDINES AS KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060113-A1 | NOVEL KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2014-04-24 | — | — | WO | disclosed |
| US-20120329785-A1 | Novel kinase inhibitors | ORIGENIS GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20120329780-A1 | Novel kinase inhibitors | ORIGENIS GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-5931168-A | Applicator for coloring hair or fibers and methods for making and using same | ABERCROMBIE TRACY HILL (US) | 1999-08-03 | — | — | US | disclosed |
| US-5845653-A | Applicator for coloring hair or fibers and methods for making and using same | ABERCROMBIE TRACY H (US) | 1998-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329780-A1 | Novel kinase inhibitors | LRRK2, MYLK2, MYLK | CYP2D6 3687/4885CYP19A1 2325/4885CYP2C9 3823/4885 |
| US-20120329785-A1 | Novel kinase inhibitors | LRRK2, MYLK2, MYLK3 | CYP2D6 4479/4885CYP19A1 4833/4885CYP2C9 4631/4885 |
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | ABL1, TH, CYP3A43 | CYP2D6 20/4885CYP19A1 1107/4885CYP2C9 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.